Application of proteoglycan extracted from the nasal cartilage of salmon heads for ex vivo expansion of hematopoietic progenitor cells derived from human umbilical cord blood

Glycoconjugate Journal

Volumn 24, Issue 4-5, 2007, Pages 251-258

  Kashiwakura, Ikuo ^a   Takahashi, Kenji ^a   Takagaki, Keiichi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

CD34+ cells; Ex vivo expansion; Hematopoietic progenitor cells; Proteoglycan

Indexed keywords

INTERLEUKIN 3; PROTEOGLYCAN; STEM CELL FACTOR; THROMBOPOIETIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL PROLIFERATION; COLONY FORMING UNIT; CONTROLLED STUDY; ERYTHROCYTE; EX VIVO STUDY; GRANULOCYTE; HEAD; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MACROPHAGE; MEGAKARYOCYTE; NONHUMAN; NOSE CARTILAGE; PRIORITY JOURNAL; SALMON; UMBILICAL CORD BLOOD;

ANIMALS; CELL PROLIFERATION; CYTOKINES; FETAL BLOOD; HEAD; HEMATOPOIETIC STEM CELLS; HUMANS; NASAL SEPTUM; PROTEOGLYCANS; SALMON;

EID: 34249889553     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-007-9033-4     Document Type: Article

References (37)

1. Graham, G.J., Wright, E.G.: Haemopoietic stem cells: their heterogeneity and regulation. Int. J. Exp. Pathol. 78, 197-218 (1997)
2. Ogawa, M.: Differentiation and proliferation of hematopoietic stem cells. Blood 81, 2844-2853 (1993)
3. Long, M.W.: Blood cell cytoadhesion molecules. Exp. Hematol. 20, 288-301 (1992)
4. Nietfeld, J.J.: Cytokines and proteoglycans. Experientia 49, 456-469 (1993)
5. Yoder, M.C., Williams, D.A.: Matrix molecule interactions with hematopoietic stem cells. Exp. Hematol. 23, 961-967 (1995)
6. Gallagher, J.T., Spooncer, E., Dexter, T.M.: Role of the cellular matrix in haemopoiesis I. Synthesis of glycosaminoglycans by mouse bone marrow cell cultures. J. Cell Sci. 63, 155-171 (1983)
7. Kirby, S.L., Bentley, S.A.: Proteoglycan synthesis in two murine bone marrow stromal cell lines. Blood 70, 1777-1783 (1987)
8. Roberts, R., Gallagher, J., Spooncer, E., Allen, T.D., Bloomfield, F., Dexter, T.M.: Heparan sulfate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature 332, 376-378 (1988)
9. Siczkowski, M., Clarke, D., Gordon, M.Y.: Binding of primitive hematopoietic progenitor cells to marrow stromal cells involves heparan sulfate. Blood 80, 912-919 (1992)
10. Simmons, P.J., Levesque, J.P., Zannettino, A.C.: Adhesion molecules in haemopoiesis. Baillieres Clin Haematol. 10, 485-505 (1997)
11. Klein, G.: The extracellular matrix of the hematopoietic microenvironment. Experientia 51, 914-926 (1995)
12. Majima, M., Takagaki, K., Sudo, S., Yoshihara, S., Kudo, Y., Yamagishi, S.: Effect of proteoglycan on experimental colitis. In Endo, M. (ed.) New Developments in Glycomedicine, Excepta Medica International Congress series, pp. 221-224, no.1223. Elsevier, Amsterdam (2001)
13. Hascall, V.C., Sajdera, S.W.: Physical properties and polydispersity of proteoglycan from bovine nasal cartilage. J. Biol. Chem. 245, 4920-4930 (1970)
14. Oegema, T.R. Jr, Hascall, V.C., Dziewiatkowski, D.D.: Isolation and characterization of proteoglycans from the swarm rat chondrosarcoma. J. Biol. Chem. 250, 6151-6159 (1975)
15. Kashiwakura, I., Takahashi, T.A.: Basic fibroblast growth factor-stimulated ex vivo expansion of haematopoietic progenitor cells from human placental and umbilical cord blood. Br. J. Haematol. 122, 479-488 (2003)
16. Gupta, P., McCarthy, J.B., Verfaillie, C.M.: Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells. Blood 87, 3229-3236 (1996)
17. Gupta, P., Oegema, T.R. Jr, Brazil, J.J., Dudek, A.Z., Slungaard, A., Verfaillie, C.M.: Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche. Blood 92, 4641-4651 (1998)
18. Gupta, P., Oegema, T.R. Jr, Brazil, J.J., Dudek, A.Z., Slungaard, A., Verfaillie, C.M.: Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins. Blood 95, 147-155 (2000)
19. Kashiwakura, I., Teramachi, T., Kakizaki, I., Takagi, Y., Takahashi, T.A., Takagaki, K.: The effects of glycosaminoglycans on thrombopoietin-induced megakaryocytopoiesis. Haematologica 91, 1-9 (2006)
20. Murata, K.: Polydisperse distribution of acidic glycosaminoglycans in bovine kidney tissue. Connect. Tissue Res. 4, 131-140 (1976)
21. Alvarez-Silva, M., Borojevic, R.: GM-CSF and IL-3 activities in schistosomal liver granulomas are controlled by stromaassociated heparan sulfate proteoglycans. J. Leukoc. Biol. 59, 435-441 (1996)
22. Seiffert, D.: The glycosaminoglycan binding site governs ligand binding to the somatomedin B domain of vitronectin. J. Biol. Chem. 272, 9971-9978 (1997)
23. Moore, M.A., Hoskins, I.: Ex vivo expansion of cord blood-derived stem cells and progenitors. Blood Cells 20, 468-4679 (1994)
24. Traycoff, C.M., Abboud, M.R., Laver, J. et al.: Ex vivo expansion of CD34+ cells from purified adult human bone marrow and umbilical cord blood hematopoietic progenitor cells. Prog. Clin. Biol. Res. 389, 385-391 (1994)
25. Ornitz, D.M., Herr, A.B., Nilsson, M., Westman, J., Svahn, C.-M., Waksman, G.: FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides. Science 268, 432-436 (1995)
26. Faham, S., Hileman, R.E., Fromm, J.R., Linhardt, R.J., Rees, D.C.: Heparin structure and interactions with basic fibroblast growth factor. Science 271, 1116-1120 (1996)
27. Kato, M., Wang, H., Kainulainen, V., et al.: Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2. Nat. Med. 4, 691-697 (1998)
28. Modrowski, D., Lomri, A., Marie, P.J.: Glycosaminoglycans bind granulocyte-macrophage colony-stimulating factor and modulate its mitogenic activity and signaling in human osteoblastic cells. J. Cell. Physiol. 177, 187-195 (1998)
29. Bruno, E., Luikart, S.D., Long, M.W., Hoffman, R.: Marrow-derived heparin sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines. Exp. Hematol. 23, 1212-1217 (1995)
30. Roberts, R., Gallagher, J., Spooncer, E., et al.: Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature 332, 376-378 (1988)
31. Ivanovic, Z.: Interleukin-3 and ex vivo maintenance of hematopoietic stem cells: facts and controversies. Eur, Cytokine Netw. 15, 6-13 (2004)
32. Smith, M.A., Pallister, C.J., Smith, J.G.: Stem cell factor: biology and relevance to clinical practice. Acta Haematol. 105, 143-150 (2001)
33. Conget, P., Minguell, J.J.: IL-3 increases surface proteoglycan synthesis in haemopoietic progenitors and their adhesiveness to the heparin-binding domain of fibronectin. Br. J. Haematol. 89, 1-7 (1995)
34. Laughlin, M.J., Barker, J., Bambach, B., Koc, O.N., Rizzieri, D.A., Wagner, J.E., Gerson, S.L., Lazarus, H.M., Cairo, M., Stevens, C.E., Rubinstein, P., Kurtzberg, J.: Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N. Engl. J. Med. 344, 1815-1822 (2001)
35. Cohena, Y., Nagler, A.: Hematopoietic stem-cell transplantation using umbilical-cord blood. Leuk. Lymphoma. 44, 1287-1299 (2003)
36. Reiffers, J., Cailliot, C., Dazey, B., Attal, M., Caraux, J., Boiron, J.M.: Abrogation of post-myeloablative chemotherapy neutropenia by ex vivo expanded autologous CD34-positive cells. Lancet 354, 1092-1093 (1999)
37. Rubinstein, P., Carrier, C., Scaradavou, A., Kurtzberg, J., Adamson, J., Migliaccio, A.R., Berkowitz, R.L., Cabbad, M., Dobrila, N.L., Taylor, P.E., Rosenfield, R.E., Stevens, C.E.: Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N. Engl. J. Med. 339, 1565-1577 (1998)